EUVIMEDEUVIMED entdecken
Crossref

Pharmacological inhibition of IRAK1/4 ameliorates high-fat diet-induced vascular dysfunction and cognitive impairment

Dinesh Kumar, Sakesh Kumar, Heena Agarwal, Gagandeep Kaur, Prem N Yadav, Manoj Kumar Barthwal

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-11518-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Dinesh Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, U.P, India. Hauptthemen laut MEDLINE: Interleukin-1 Receptor-Associated Kinases, Cognitive Dysfunction. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Interleukin 1 receptor-associated kinase 1, 4 (IRAK 1/4) inhibitor exerts anti-inflammatory and immuno-modulatory effects; however, its role in high-fat diet-induced vascular dysfunction and cognitive impairment is not known, and therefore investigated in the present study. METHOD & RESULTS: Animals were fed either a high-fat diet (60% Kcal fat) or a chow diet (10% Kcal fat) for 12 weeks to induce hyperlipidemia and weight gain. High-fat diet-fed animals were then treated with vehicle, IRAK1/4 inhibitor (2.2 mg/kg, i.p.) and a reference drug, Orlistat (20 mg/kg, oral gavage), for 4 additional weeks. Protein levels were assessed by ELISA or Western blotting, and mRNA by RT-PCR. IRAK1/4 inhibitor and reference drug, Orlistat treatment, prevented HFD-induced increase in body weight gain, fasting blood glucose and plasma lipids, improved discrimination between the familiar and the novel arm in the Y-Maze test, alleviated percent avoidance in two-way active avoidance, and freezing percent in contextual fear conditioning test. The treatments attenuated the levels of systemic inflammatory cytokines IL-1β, CRP, as well as TNF-α, IL-6 and protein expression of Iba-1, GFAP, HIF-1α, and restored the BDNF levels in the pre-frontal cortex of HFD-fed treated mice. IRAK 1/4 inhibitor exerted these effects by blocking proteasomal degradation of IκB-α protein in the pre-frontal cortex of HFD-treated mice. In addition, the treatments prevented HFD-induced increase in vascular ICAM-1, VCAM-1, MCP-1, COX-1 and COX-2 mRNA expression, and restored vascular eNOS mRNA levels as well as the Acetylcholine (300 ρM-300 μM) induced relaxations of PE (1 µM) pre-contracted aortic rings. CONCLUSION: IRAK1/4 inhibitor attenuates HFD-induced inflammation, vascular dysfunction and cognitive impairment in obese mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-1 Receptor-Associated KinasesCognitive DysfunctionAnimalsDiet, High-FatMiceMaleMice, Inbred C57BLOrlistatVascular DiseasesInflammationHyperlipidemiasCytokinesObesity

Stichwörter der Autor:innen

Cognitive dysfunctionEndothelial dysfunctionFear conditioningIRAK 1/4InflammationOrlistat

Substanzen

Interleukin-1 Receptor-Associated KinasesIrak1 protein, mouseIrak4 protein, mouseOrlistatCytokines

Autor:innen und Institutionen

  • Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, U.P, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Division of Neuroscience and Ageing Biology, CSIR-Central Drug Research Institute, Lucknow, 226031, U.P, India.
  • Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, U.P, India. manojbarthwal@cdri.res.in.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. manojbarthwal@cdri.res.in.

Zitieren

APA

Kumar, D., Kumar, S., Agarwal, H., Kaur, G., Yadav, P. N., & Barthwal, M. K. (2026). Pharmacological inhibition of IRAK1/4 ameliorates high-fat diet-induced vascular dysfunction and cognitive impairment. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-11518-2

Vancouver

Kumar D, Kumar S, Agarwal H, Kaur G, Yadav PN, Barthwal MK. Pharmacological inhibition of IRAK1/4 ameliorates high-fat diet-induced vascular dysfunction and cognitive impairment. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-11518-2

BibTeX
@article{Kumar2026,
  author = {Kumar, Dinesh and Kumar, Sakesh and Agarwal, Heena and Kaur, Gagandeep and Yadav, Prem N and Barthwal, Manoj Kumar},
  title = {Pharmacological inhibition of IRAK1/4 ameliorates high-fat diet-induced vascular dysfunction and cognitive impairment},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-11518-2}
}
Kostenlos starten →